Delivery Order SPE2DR25D3004-SPE2DR26FXRT1
Award Date 12/23/25
Potential Completion Date 1/15/26
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count) with a contract value of $3,676.12 under a firm fixed-price arrangement. This award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside, competitively awarded order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count supply) valued at $4,027.70 under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a non-set-aside competitive award executed as a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG Capsule in a 30-count quantity under a firm fixed-price contract with a ceiling value of $3,676.12. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14.7K to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract valued at $11,622.18. The award, issued on November 26, 2025, with an ultimate completion date of December 18, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of INGREZZA 60 mg capsules (30-count units) valued at $4,049.61. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract completion date is set for June 24, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count), with an ultimate completion date of May 28, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a pharmaceutical treatment indicated for tardive dyskinesia, a neurological movement disorder,...